Join us for an exclusive investor showcase on March 11, 2026 featuring Pre-Seed, Seed, and Series A companies from IndieBio NY’s portfolio—all working to advance human and planetary health.

This event reflects IndieBio NY’s core strength: derisking biology and business. Many teams are already revenue-touching, in-clinic, or scaling early customers, and all are operating at meaningful inflection points across Seed and Series A.